- +152.5% price growth over the last year
- Beat earnings estimates in 3 of the last 4 quarters
- Low bankruptcy risk (Altman Z-Score: 38.22)
Tyra Biosciences, Inc. stock upgraded from Strong Sell Candidate to Sell Candidate after Friday trading session
(Updated on Jun 05, 2026)
The Tyra Biosciences, Inc. stock price fell by -1.99% on the last day (Friday, 5th Jun 2026) from $27.18 to $26.64. During the last trading day the stock fluctuated 5.23% from a day low at $26.41 to a day high of $27.79. The price has fallen in 7 of the last 10 days and is down by -19.32% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 0 shares were bought and sold for approximately $0 .
The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($27.78) are considered to be a "second chance" to get out. According to the fan-theory $19.87 will represent the new bottom line of the next trend, but it is far too early to say this for certain.
TYRA Signals & Forecast
There are few to no technical positive signals at the moment. The Tyra Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $29.66 and $33.84. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -20.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Tyra Biosciences, Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $1.38 between high and low, or 5.23%. For the last week the stock has had daily average volatility of 7.86%
Tyra Biosciences, Inc. is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TYRA) For The Upcoming Trading Day Of Monday 8th
For the upcoming trading day on Monday, 8th we expect Tyra Biosciences, Inc. to open at $26.95, and during the day (based on 14 day Average True Range), to move between $25.67 and $27.61, which gives a possible trading interval of +/-$1.94 (+/-7.55%) up or down from last closing price. If Tyra Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 7.55% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $27.18, some $0.540 (2.03%) from the current price of $26.64, our system finds the risk reward not very attractive.
Is Tyra Biosciences, Inc. stock A Buy?
Tyra Biosciences, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score:
-2.849
Sell Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 8, 2026 - $26.95 ( 1.15%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TYRA Performance
Trading levels for TYRA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 28.33 | 6.33% |
| R2 | 27.80 | 4.35% |
| R1 | 27.47 | 3.13% |
| Price | 26.64 | |
| S1 | 26.42 | -0.83% |
| S2 | 26.09 | -2.05% |
| S3 | 25.57 | -4.03% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 30.39 | 14.08% |
| R2 | 28.69 | 7.70% |
| R1 | 27.18 | 2.03% |
| Price | 26.64 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Tyra Biosciences, Inc. Stock.
Buy TYRA